Integrated Proteins Ltd
Incorporated in 1992, Integrated Proteins Ltd is in the business of trading in various oil seeds and agri commodities.[1]
- Market Cap ₹ 17.2 Cr.
- Current Price ₹ 46.9
- High / Low ₹ 78.3 / 31.2
- Stock P/E
- Book Value ₹ 6.31
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 7.43 times its book value
- Promoter holding is low: 13.0%
- Promoter holding has decreased over last 3 years: -33.2%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Dividend Payout % |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | 35% |
5 Years: | 78% |
3 Years: | 56% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Equity Capital |
Reserves |
Total Liabilities |
CWIP |
Investments |
Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Debtor Days |
Inventory Days |
Days Payable |
Cash Conversion Cycle |
Working Capital Days |
ROCE % |
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30, 32 And 33 Of The SEBI
(LODR) Regulations, 2015, As Amended ('SEBI LODR").
2d - Integrated Proteins reports Q1 FY26 unaudited results; marginal profit Rs.0.01 lakh; no fund usage deviation.
-
Board Meeting Intimation for Prior Intimation Of Board Meeting And Trading Window Regulation 29 (1)(A) Of The SEBI (LODR) Regulation, 2015
8 Aug - Board meeting on 14 Aug to approve Q1 June 2025 results; trading window reopens 16 Aug.
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 8 Aug
-
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
8 Aug - Vedankit Traders acquires 5.34% stake in Integrated Proteins via preferential allotment on 07-08-2025.
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 8 Aug
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
IPL is engaged in the business of manufacturing, trading, and processing various oilseeds. There was an operational shift in the business as:
a) The company ceased operations in the solvent extraction of oilseeds.
b) In FY24, the company explored one of its main objectives and commenced trading in agri
commodities.